XTRACT ONE TECHNOLOGIES INC (XTRA.CA) Fundamental Analysis & Valuation

TSX:XTRA • CA98422Q1063

0.48 CAD
-0.03 (-5.88%)
Last: Mar 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This XTRA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall XTRA gets a fundamental rating of 3 out of 10. We evaluated XTRA against 13 industry peers in the Aerospace & Defense industry. XTRA may be in some trouble as it scores bad on both profitability and health. XTRA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. XTRA.CA Profitability Analysis

1.1 Basic Checks

  • In the past year XTRA has reported negative net income.
  • XTRA had a negative operating cash flow in the past year.
  • XTRA had negative earnings in each of the past 5 years.
  • In the past 5 years XTRA always reported negative operating cash flow.
XTRA.CA Yearly Net Income VS EBIT VS OCF VS FCFXTRA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • XTRA's Return On Assets of -50.37% is on the low side compared to the rest of the industry. XTRA is outperformed by 76.92% of its industry peers.
  • XTRA has a Return On Equity (-115.48%) which is in line with its industry peers.
Industry RankSector Rank
ROA -50.37%
ROE -115.48%
ROIC N/A
ROA(3y)-60.36%
ROA(5y)-86.91%
ROE(3y)-100.39%
ROE(5y)-121.9%
ROIC(3y)N/A
ROIC(5y)N/A
XTRA.CA Yearly ROA, ROE, ROICXTRA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

1.3 Margins

  • With an excellent Gross Margin value of 63.66%, XTRA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for XTRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XTRA.CA Yearly Profit, Operating, Gross MarginsXTRA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. XTRA.CA Health Analysis

2.1 Basic Checks

  • XTRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, XTRA has more shares outstanding
  • XTRA has more shares outstanding than it did 5 years ago.
  • XTRA has a worse debt/assets ratio than last year.
XTRA.CA Yearly Shares OutstandingXTRA.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
XTRA.CA Yearly Total Debt VS Total AssetsXTRA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • XTRA has an Altman-Z score of -4.59. This is a bad value and indicates that XTRA is not financially healthy and even has some risk of bankruptcy.
  • XTRA has a Altman-Z score of -4.59. This is in the lower half of the industry: XTRA underperforms 76.92% of its industry peers.
  • XTRA has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • XTRA has a Debt to Equity ratio of 0.08. This is amongst the best in the industry. XTRA outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -4.59
ROIC/WACCN/A
WACC9.15%
XTRA.CA Yearly LT Debt VS Equity VS FCFXTRA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • XTRA has a Current Ratio of 1.71. This is a normal value and indicates that XTRA is financially healthy and should not expect problems in meeting its short term obligations.
  • XTRA's Current ratio of 1.71 is amongst the best of the industry. XTRA outperforms 84.62% of its industry peers.
  • A Quick Ratio of 1.35 indicates that XTRA should not have too much problems paying its short term obligations.
  • XTRA has a Quick ratio of 1.35. This is amongst the best in the industry. XTRA outperforms 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.35
XTRA.CA Yearly Current Assets VS Current LiabilitesXTRA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. XTRA.CA Growth Analysis

3.1 Past

  • XTRA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.49%.
  • XTRA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.14%.
  • XTRA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.26% yearly.
EPS 1Y (TTM)3.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-12.14%
Revenue growth 3Y56.42%
Revenue growth 5Y46.26%
Sales Q2Q%26.69%

3.2 Future

  • XTRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.
  • The Revenue is expected to grow by 62.88% on average over the next years. This is a very strong growth
EPS Next Y49%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year79.3%
Revenue Next 2Y62.88%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XTRA.CA Yearly Revenue VS EstimatesXTRA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
XTRA.CA Yearly EPS VS EstimatesXTRA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2024 2025 2026 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

1

4. XTRA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • XTRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XTRA.CA Price Earnings VS Forward Price EarningsXTRA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XTRA.CA Per share dataXTRA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04

4.3 Compensation for Growth

  • A more expensive valuation may be justified as XTRA's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XTRA.CA Dividend Analysis

5.1 Amount

  • XTRA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XTRA.CA Fundamentals: All Metrics, Ratios and Statistics

XTRACT ONE TECHNOLOGIES INC

TSX:XTRA (3/9/2026, 7:00:00 PM)

0.48

-0.03 (-5.88%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-04
Earnings (Next)06-03
Inst Owners0.52%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap124.75M
Revenue(TTM)14.82M
Net Income(TTM)-11.94M
Analysts82.5
Price Target1.1 (129.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.96%
Min EPS beat(2)1.96%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)-10.29%
Min EPS beat(4)-96.08%
Max EPS beat(4)50.98%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.37%
Min Revenue beat(2)-26.53%
Max Revenue beat(2)-2.21%
Revenue beat(4)0
Avg Revenue beat(4)-16.37%
Min Revenue beat(4)-34.03%
Max Revenue beat(4)-2.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.42
P/FCF N/A
P/OCF N/A
P/B 12.07
P/tB 20.73
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.06
BVpS0.04
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -50.37%
ROE -115.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.66%
FCFM N/A
ROA(3y)-60.36%
ROA(5y)-86.91%
ROE(3y)-100.39%
ROE(5y)-121.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.64%
Cap/Sales 3.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.35
Altman-Z -4.59
F-Score3
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)20.53%
Cap/Depr(5y)19.86%
Cap/Sales(3y)3.35%
Cap/Sales(5y)13.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y49%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.14%
Revenue growth 3Y56.42%
Revenue growth 5Y46.26%
Sales Q2Q%26.69%
Revenue Next Year79.3%
Revenue Next 2Y62.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year77.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y54.31%
OCF growth 3YN/A
OCF growth 5YN/A

XTRACT ONE TECHNOLOGIES INC / XTRA.CA FAQ

What is the fundamental rating for XTRA stock?

ChartMill assigns a fundamental rating of 3 / 10 to XTRA.CA.


Can you provide the valuation status for XTRACT ONE TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 1 / 10 to XTRACT ONE TECHNOLOGIES INC (XTRA.CA). This can be considered as Overvalued.


How profitable is XTRACT ONE TECHNOLOGIES INC (XTRA.CA) stock?

XTRACT ONE TECHNOLOGIES INC (XTRA.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for XTRA stock?

The financial health rating of XTRACT ONE TECHNOLOGIES INC (XTRA.CA) is 3 / 10.